Log In
Print
BCIQ
Print
Print this Print this
 

Methylene Blue MMX (CB-17-01)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals S.p.A.
DescriptionOral colon-release formulation of methylene blue delivered using MMX multi-matrix system technology
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose lesions, polyps and adenomas in the colon
Regulatory Designation

U.S. - Special Protocol Assessment (Diagnose lesions, polyps and adenomas in the colon)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today